Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: November 1, 1999
Last updated: August 1, 2013
Last verified: April 2001